A retrospective study of health care resource utilization in patients with chronic or episodic migraine (CM/EM) initiating fremanezumab treatment
Latest Information Update: 04 Jun 2021
At a glance
- Drugs Fremanezumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 04 Jun 2021 New trial record
- 22 Apr 2021 Results presented at the 73rd Annual Meeting of the American Academy of Neurology